Relay Therapeutics, Inc. (RLAY)
20.06
+0.30
(+1.52%)
USD |
NASDAQ |
Aug 25, 09:48
Relay Therapeutics Shareholders Equity (Quarterly) : 890.01M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 890.01M |
| March 31, 2026 | 642.18M |
| December 31, 2025 | 567.06M |
| September 30, 2025 | 607.71M |
| June 30, 2025 | 665.66M |
| March 31, 2025 | 721.08M |
| December 31, 2024 | 777.79M |
| September 30, 2024 | 838.86M |
| June 30, 2024 | 681.74M |
| March 31, 2024 | 745.76M |
| December 31, 2023 | 752.00M |
| September 30, 2023 | 778.37M |
| June 30, 2023 | 810.12M |
| March 31, 2023 | 883.41M |
| Date | Value |
|---|---|
| December 31, 2022 | 950.22M |
| September 30, 2022 | 999.77M |
| June 30, 2022 | 779.64M |
| March 31, 2022 | 841.97M |
| December 31, 2021 | 897.81M |
| September 30, 2021 | 571.09M |
| June 30, 2021 | 618.53M |
| March 31, 2021 | 732.79M |
| December 31, 2020 | 763.29M |
| September 30, 2020 | 713.52M |
| June 30, 2020 | 312.39M |
| March 31, 2020 | 335.43M |
| December 31, 2019 | 357.34M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 757.49M |
| United Therapeutics Corp. | 6.400B |
| AbbVie, Inc. | -5.935B |
| TG Therapeutics, Inc. | 604.08M |
| Travere Therapeutics, Inc. | 24.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 967.46M |
| Total Liabilities (Quarterly) | 77.45M |
| Debt to Equity Ratio | 0.0344 |
| Current Ratio | 18.27 |
| Net Debt Paydown Yield | 0.08% |